Lever
Lifestyle
- Regular physical exercise
- Stress management techniques
- Adequate sleep
Blutwerte · Marker
CD4/CD8-Ratio
T-Cell Ratio · T-Helfer/Suppressor-Ratio · CD4:CD8
ImmunsystemZeitabhängig
- Einheit:
- ratio
- Abbreviation
- CD4/CD8
The CD4/CD8 ratio quantifies the balance between CD4+ helper T-cells and CD8+ cytotoxic T-cells in the blood.
Reference Ranges
Reference
1–3.5ratio
1
1.5
2.5
3.5
LowNormalHigh
Reference
Optimal
Unit · ratioReference ranges may vary slightly based on laboratory standards and population demographics.
Overview
Übersicht
The CD4/CD8 ratio, also known as the T-cell ratio, measures the balance between CD4+ helper T-cells and CD8+ cytotoxic T-cells in the blood. This ratio is a critical indicator of immune system health and function. CD4+ T-cells are essential for initiating and orchestrating the immune response, while CD8+ T-cells are primarily responsible for killing infected cells and controlling viral infections. Researchers have found that the CD4/CD8 ratio is an important biomarker in various clinical settings. A decreased ratio is often observed in conditions such as HIV infection, where CD4+ T-cells are depleted, leading to immune dysfunction. Conversely, an elevated ratio can be indicative of autoimmune diseases or chronic inflammatory conditions, where CD8+ T-cell activity may be suppressed. In the context of athletic performance and biohacking, maintaining an optimal CD4/CD8 ratio is considered beneficial for immune resilience and recovery. Athletes and biohackers may monitor this ratio to ensure their immune system is balanced, potentially enhancing recovery and reducing the risk of infections. However, researchers observed that factors such as stress, acute infections, and certain medications can confound the CD4/CD8 ratio. Time-of-day variations and fasting status may also influence measurements, necessitating standardized testing conditions for accurate assessment.
Klinische Bedeutung
A reduced CD4/CD8 ratio is clinically significant in conditions like HIV, indicating immune suppression. An elevated ratio may suggest autoimmune disorders or chronic inflammation. Monitoring this ratio helps assess immune system health.
Dynamics
Trend Interpretation
Rising Values
A rising CD4/CD8 ratio may indicate improving immune function or a shift towards autoimmune activity. Retest in 3-6 months if changes are unexpected.
Falling Values
A falling CD4/CD8 ratio may suggest immunosuppression or active infection. Further investigation may be warranted.
Re-test Interval
6 months if outside optimal range
Etiology
Causes — High & Low
Cause
Elevated Levels
- Autoimmune diseases
- Chronic inflammatory conditions
- Stress
- Certain medications
Cause
Low Levels
- HIV infection
- Immunodeficiency disorders
- Acute viral infections
- Chronic stress
Protocol
How to Optimize
Lever
Nutrition
- Balanced diet rich in fruits and vegetables
- Omega-3 fatty acids
- Probiotics
Lever
Supplementation
- Vitamin D
- Zinc
Note:
Consult a healthcare provider before starting any new supplement regimen, particularly if you have underlying health conditions.
Testing Guidelines
✓Fasting Not Required
🕐Time-Sensitive
T-cell counts can vary throughout the day; consistent timing is recommended for comparability.
Testing Frequency
Annually for healthy adults, more frequently if monitoring immune-related conditions.
Interfering Factors
- Recent infections
- Medications affecting immune function
- Acute stress
Open Research Questions
Current research suggests that reference ranges for the CD4/CD8 ratio in various conditions, such as cancer and autoimmune diseases, remain inadequately defined, leading to uncertainty in optimal targets and potential confounders. Emerging research directions include the role of this ratio in predicting responses to immunotherapy and its implications in aging. However, clinical questions remain unanswered regarding the specific mechanisms by which the CD4/CD8 ratio influences disease progression and treatment outcomes across different populations.
27 Research Publications
259
Total Citations
19
Human/RCT
1.9
Avg. Influence
2025
Latest
Sort
Filter
01Top
#01
Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis.
HumanInfluence3.0
57
This study focused on differentiating erythrodermic cutaneous T-cell lymphoma from atopic dermatitis. Researchers found that a high CD4/CD8 ratio in lesional skin was helpful in diagnosing erythrodermic cutaneous T-cell lymphoma, indicating its potential as a diagnostic marker.
02Top
#02
Hyper-IgE syndromes: reviewing PGM3 deficiency.
ReviewInfluence3.0
42
Researchers found that mutations causing hyper-IgE syndromes lead to a reversed CD4/CD8 ratio, indicating T-cell proliferation defects. This study provides insights into the immune dysfunction associated with these genetic mutations. The findings could guide future research on immune-related disorders.
03Top
#03
Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer.
Human
22
Researchers analyzed the prognostic role of peripheral blood T-cell subsets in triple-negative breast cancer (TNBC). They found that a higher CD4+/CD8+ ratio was associated with better treatment efficacy and longer progression-free and overall survival.
04
#04
CD4/CD8 Ratio and Cancer Risk Among Adults With HIV.
HumanInfluence3.0
22
Researchers observed that a low CD4/CD8 ratio in people with HIV is linked to an increased risk of various cancers. This study analyzed data from a large cohort and found that lower ratios were predictive of cancer incidence. The findings suggest that monitoring this ratio could be important for cancer risk assessment.
05
#05
Inflammatory mediators and lung abnormalities in HIV: A systematic review.
ReviewInfluence1.0
21
Researchers conducted a systematic review to assess the impact of inflammatory markers on lung function in individuals with HIV and pneumonia. They found that the CD4/CD8 ratio was associated with lung abnormalities, indicating its potential role as a biomarker in this population.
06
#06
Immunological Biomarkers of COVID-19.
Lei Rongwei & Mohan Chandra · Critical reviews in immunology · 2020
ReviewInfluence1.0
19
This review examined various hematological and inflammatory biomarkers in COVID-19, noting significant changes in immune cell ratios, including CD4/CD8 ratios. Researchers highlighted the importance of these biomarkers for understanding disease severity and potential treatment strategies. The study underscores the complexity of immune responses in COVID-19.
Key findings
- 01Researchers observed significant changes in blood cell counts, such as lymphocytes and neutrophils, in COVID-19 patients.
- 02They identified key inflammatory markers, including interleukins and other proteins, that correlate with disease severity.
- 03The study highlighted that using a combination of biomarkers provides better diagnostic insights than relying on single markers alone.
07
#07
Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study.
Human
12
This pilot study investigated the predictive value of the CD4/CD8 lymphocyte ratio in gastric cancer patients undergoing neoadjuvant chemotherapy. Researchers found that a higher CD4+/CD8+ ratio significantly predicted a favorable treatment response.
08
#08
Low-level HIV-1 viremia affects T-cell activation and senescence in long-term treated adults in the INSTI era.
Human
11
Researchers found that low-level HIV viremia is associated with a decreased CD4/CD8 ratio and increased T-cell activation and senescence. This study suggests that low viremia may impair immune responses in HIV patients. The findings indicate potential risks for long-term health complications.
09
#09
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma.
Human
10
Researchers found that mature dendritic cells in metastatic melanoma are linked to immune responses and can predict progression-free survival when combined with the CD4/CD8 T cell ratio. They identified unique profiles of these cells that may improve immunotherapy strategies. This study highlights the importance of immune cell interactions in cancer treatment.
10
#10
Role of CD4+T, CD8+T Cells, and CD4+T/CD8+T Cell Ratio in Gastric Cancer and Its Clinical Significance.
Human
9
Researchers studied the CD4/CD8 T-cell ratio in gastric cancer patients and found that lower ratios correlated with cancer progression. The study highlights the potential of using T-cell ratios as indicators of immune response in cancer. These findings could inform immunotherapy approaches.
Publication Trend
Research publications about CD4/CD8-Ratio over time
10totalTrack your bloodwork in PepStack
Log lab results, track trends and optimize your biomarkers over time.
Legal Disclaimer
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer